Evidence map›Paper›PMID 42463292›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2026

Clinical Impact and Dynamics of Clonal Hematopoiesis with

Praful Ravi, Caiwei Zhong, Kimberly J Perez, Wanling Xie, Virginia Volpe, Gwo-Shu Mary Lee, Jonah Boardman, Emma G Pittard, Hailey Stoltenberg, Heather Jacene and 2 more

Abstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Praful RaviDana-Farber Cancer Institute, Boston, Massachusetts; praful_ravi@dfci.harvard.edu asperlin@stanford.edu.
Caiwei ZhongDana-Farber Cancer Institute, Boston, Massachusetts.
Kimberly J PerezDana-Farber Cancer Institute, Boston, Massachusetts.
Wanling XieDana-Farber Cancer Institute, Boston, Massachusetts.
Virginia VolpeDana-Farber Cancer Institute, Boston, Massachusetts.
Gwo-Shu Mary LeeDana-Farber Cancer Institute, Boston, Massachusetts.
Jonah BoardmanBrigham and Women's Hospital, Boston, Massachusetts; and.
Emma G PittardBrigham and Women's Hospital, Boston, Massachusetts; and.
Hailey StoltenbergDana-Farber Cancer Institute, Boston, Massachusetts.
Heather JaceneDana-Farber Cancer Institute, Boston, Massachusetts.
Lachelle D WeeksDana-Farber Cancer Institute, Boston, Massachusetts.
Adam S SperlingDana-Farber Cancer Institute, Boston, Massachusetts; praful_ravi@dfci.harvard.edu asperlin@stanford.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence, clinical impact, and clonal dynamics of clonal hematopoiesis (CH) in patients receiving

Indexed as

Clonal HematopoiesisDipeptidesHeterocyclic CompoundsHeterocyclic Compounds, 1-RingLutetiumProstatic NeoplasmsProstatic Neoplasms, Castration-ResistantAgedAged, 80 and overHumansMaleMutationProstate-Specific AntigenRadioisotopesDipeptidesHeterocyclic CompoundsHeterocyclic Compounds, 1-RingLutetiumProstate-Specific AntigenPSMA-617Radioisotopes177Lu-PSMA-617clonal hematopoiesisprostate cancerradiopharmaceutical therapytoxicity

Identifiers

PMID42463292
PMCPMC13635083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.